Valproic Acid and Its Amidic Derivatives as New Antivirals against Alphaherpesviruses

• Published in: Viruses Vol. 12; no. 12; p. 1356
• Main Authors: Andreu, Sabina, Ripa, Inés, Bello-Morales, Raquel, López-Guerrero, José Antonio
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 26.11.2020; MDPI
• Subjects: Acyclovir; Age; Alphaherpesvirinae - drug effects; alphaherpesvirus; Amides - chemistry; Animals; Antiepileptic agents; Antiviral activity; Antiviral agents; Antiviral Agents - chemistry; Antiviral Agents - pharmacology; Cattle; Deoxyribonucleic acid; DNA; DNA polymerase; Dose-Response Relationship, Drug; Drug dosages; Foot & mouth disease; Gene expression; Herpes simplex; Herpes viruses; Host range; Humans; Infections; Kinases; Meningitis; Metabolism; Metabolites; Microbial Sensitivity Tests; Molecular Structure; Mutation; Nervous system; Neurological diseases; Neurological disorders; Nucleoside analogs; Protein synthesis; Proteins; Reptiles & amphibians; Review; valnoctamide; Valproic acid; Valproic Acid - analogs & derivatives; Valproic Acid - pharmacology; valpromide; West Nile virus; valpromide; valproic acid; alphaherpesvirus; valnoctamide
• ISSN: 1999-4915; 1999-4915
• DOI: 10.3390/v12121356

Herpes simplex viruses (HSVs) are neurotropic viruses with broad host range whose infections cause considerable health problems in both animals and humans. In fact, 67% of the global population under the age of 50 are infected with HSV-1 and 13% have clinically recurrent HSV-2 infections. The most prescribed antiherpetics are nucleoside analogues such as acyclovir, but the emergence of mutants resistant to these drugs and the lack of available vaccines against human HSVs has led to an imminent need for new antivirals. Valproic acid (VPA) is a branched short-chain fatty acid clinically used as a broad-spectrum antiepileptic drug in the treatment of neurological disorders, which has shown promising antiviral activity against some herpesviruses. Moreover, its amidic derivatives valpromide and valnoctamide also share this antiherpetic activity. This review summarizes the current research on the use of VPA and its amidic derivatives as alternatives to traditional antiherpetics in the fight against HSV infections.